ARTV

Artiva Biotherapeutics, Inc.

NasdaqGM · Healthcare

$10.02

-4.84% today

1 insider bought $412.8K ·

last filing 2026-07-24Pro sees filings in ~15 min

Price

hover · 4 moves explained

7 buys9 sells4 8-K

Analyst consensus

$35.80target+257.3%vs $10.02 today

$23.00 low today target$41.00 high

5 analysts · ~12-month consensus · as of Jul 28. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 0 of last 4

Earnings per share · actual vs forecast

Q2 '25-13.0%

−$0.87

exp −$0.77

Q3 '25-10.0%

−$0.88

exp −$0.80

Q4 '25-5.0%

−$0.84

exp −$0.80

Q1 '26-12.7%

−$0.95

exp −$0.84

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Buy	2026-07-28	RA CAPITAL MANAGEMENT, L.P.	10% owner	0.2%Indirect	41,319	$9.99	$412.8K
Buy	2026-06-16	RA CAPITAL MANAGEMENT, L.P.	10% owner	0.7%Indirect	124,893	$8.89	$1.11M
Buy	2026-06-16	RA CAPITAL MANAGEMENT, L.P.	10% owner	0.1%Indirect	15,414	$8.99	$138.6K
Buy	2026-06-16	RA CAPITAL MANAGEMENT, L.P.	10% owner	2.4%Indirect	391,019	$8.57	$3.35M
Buy	2026-06-11	RA CAPITAL MANAGEMENT, L.P.	10% owner	3.4%Indirect	548,580	$7.91	$4.34M

Buy

RA CAPITAL MANAGEMENT, L.P.

10% owner · 0.2% of stake · 2026-07-28

$412.8K

41,319 @ $9.99

Buy

RA CAPITAL MANAGEMENT, L.P.

10% owner · 0.7% of stake · 2026-06-16

$1.11M

124,893 @ $8.89

Buy

RA CAPITAL MANAGEMENT, L.P.

10% owner · 0.1% of stake · 2026-06-16

$138.6K

15,414 @ $8.99

Buy

RA CAPITAL MANAGEMENT, L.P.

10% owner · 2.4% of stake · 2026-06-16

$3.35M

391,019 @ $8.57

Buy

RA CAPITAL MANAGEMENT, L.P.

10% owner · 3.4% of stake · 2026-06-11

$4.34M

548,580 @ $7.91

40 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →